06/15/2020
6:37 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:36 AM | Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:35 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:35 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:34 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:33 AM | Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:32 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:31 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:31 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:18 AM | Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/11/2020
6:17 AM | Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/11/2020
6:16 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:15 AM | Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:14 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:13 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:13 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:12 AM | Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:11 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:10 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:09 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2020
7:28 AM | Teva Pharmaceutical Industries (Filer)
| Form DEFA14A
| |
05/07/2020
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2020
6:57 AM | Teva Pharmaceutical Industries (Filer)
| Form DEFA14A
| |
04/22/2020
6:54 AM | Teva Pharmaceutical Industries (Filer)
| Form DEF 14A
| |
03/19/2020
3:19 PM | Teva Pharmaceutical Industries (Filer)
| Form PRE 14A
| |
03/19/2020
7:09 AM | Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2020
6:38 AM | Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2020
6:37 AM | O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2020
6:36 AM | Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2020
6:33 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2020
6:32 AM | Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2020
6:31 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2020
7:16 AM | Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2020
7:13 AM | O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2020
7:11 AM | Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2020
7:10 AM | Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2020
7:07 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2020
5:39 AM | Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:21 AM | Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:19 AM | Schultz Kare (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:18 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:17 AM | O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:16 AM | Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:14 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:12 AM | Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:11 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:10 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:08 AM | Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:06 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2020
8:59 AM | Teva Pharmaceutical Industries (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2020
6:17 PM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
6:26 AM | Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
6:25 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
6:23 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
6:22 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
6:21 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
6:19 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
6:08 AM | Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
6:06 AM | Schultz Kare (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
6:05 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
6:04 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
6:03 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2020
6:07 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2020
6:06 AM | Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2020
6:04 AM | Schultz Kare (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2020
6:03 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2020
6:02 AM | O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2020
6:01 AM | Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2020
5:57 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2020
5:56 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2020
5:53 AM | Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2020
5:52 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2020
5:08 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2020
5:05 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/03/2019
5:32 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2019
3:04 PM | Teva Pharmaceutical Industries (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2019
6:05 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2019
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2019
5:46 AM | McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2019
6:19 AM | Schultz Kare (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2019
4:11 PM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2019
5:42 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2019
7:15 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2019
6:19 AM | O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
6:19 AM | Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
6:17 AM | McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
6:12 AM | Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
6:11 AM | Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
6:10 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2019
5:58 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2019
6:05 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2019
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2019
5:28 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:26 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:26 AM | Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:18 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:17 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:16 AM | Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:11 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:08 AM | GOLDBERG MURRAY A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
